青少年向成年过渡期的人乳头瘤病毒(HPV)疫苗接种
本研究通过半结构化访谈和焦点小组,探讨大学生和医疗服务提供者对HPV疫苗接种的看法。结果显示,年轻成人受父母和医生建议影响,对男性获益认知不足,并面临接种状态、保险覆盖和日程安排等障碍。提供者建议改善校园宣传时机和临床基础设施。
要点
- 年轻成人HPV疫苗接种决策受父母观点和医生推荐影响较大。
- 学生常缺乏对男性接种获益的认知,并担忧疫苗安全性和副作用。
- 接种障碍包括接种状态不确定、保险覆盖不清及学业日程冲突。
核心结论
- 大学时期虽是接触年轻成人进行HPV疫苗接种的时机,但父母影响、独立决策、接种状态认知缺乏及多层面障碍可能阻碍接种。
研究设计与样本
- 在大型公立大学学生健康中心开展半结构化访谈(n=27)和四个焦点小组(n=18),并对医疗服务提供者进行半结构化访谈(n=6)。
主要发现
- 许多年轻成人将父母观点和医疗提供者建议视为决策影响因素。
- 学生认为预防宫颈癌是HPV疫苗主要获益,并将性活动视为HPV感染风险因素。
- 学生常缺乏疫苗对男性获益的知识,并对被视为新疫苗的安全性和副作用表达担忧。
- 接种后勤障碍包括接种状态不确定、保险覆盖不清及平衡疫苗日程与学业义务的担忧。
- 提供者疫苗推荐受卫生系统因素影响,包括临床基础设施、推荐和记录流程及就诊优先级。
关键数值与推荐
- HPV疫苗目前获批用于45岁以下成人,补种接种推荐至26岁。
临床怎么用
- 建议改善校园宣传的时机和信息传递,并加强临床基础设施以促进HPV疫苗接种。
局限性
- 研究仅在一所大型公立大学的学生健康中心进行,样本可能限制普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Young adulthood is characterized by changes in health care decision-making, insurance coverage, and sexual risk. Although the human papillomavirus (HPV) vaccine is now approved for adults up to age 45, and catch-up vaccination is currently recommended up through age 26, vaccination rates remain low in young adults. This study explored perspectives on HPV vaccination among young adults receiving care at the student health center of a large public university. METHODS: We conducted semi-structured interviews (n = 27) and four focus groups with female and male undergraduate and graduate students (n = 18) and semi-structured interviews with health care providers (n = 6). Interviews and focus groups explored perceived risk of HPV infection, benefits of the HPV vaccine, and motivations for and barriers to HPV vaccination. RESULTS: Many young adults cited their parents' views and recommendations from medical providers as influential on their decision-making process. Students perceived that cervical cancer prevention was a main benefit of the HPV vaccine and sexual activity was a risk factor for HPV infection. Students often lacked knowledge about the vaccine's benefits for males and expressed some concerns about the safety and side effects of a vaccine perceived as new. Logistical barriers to vaccination included uncertainty over vaccination status and insurance coverage for the vaccine, and concerns about balancing the vaccine schedule with school obligations. Providers' vaccine recommendations were impacted by health system factors, including clinical infrastructure, processes for recommending and documenting vaccination, and office visit priorities. Suggested vaccination promotion strategies included improving the timing and messaging of outreach efforts on campus and bolstering clinical infrastructure. CONCLUSIONS: Although college may be an opportune time to reach young adults for HPV vaccination, obstacles including navigating parental influence and independent decision-making, lack of awareness of vaccination status, and numerous logistical and system-level barriers may impede vaccination during this time.
引用
- Glenn BA, Nonzee NJ, Tieu L, et al. Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood. Vaccine. 2021. PMID: 33992435. doi:10.1016/j.vaccine.2021.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。